Invest in the Future

Indiana is home to globally recognized companies, a deep pipeline of startups, and a connected ecosystem of investors and innovation partners.

Why Indiana?

Indiana’s life sciences ecosystem, strategic partnerships, and strong investments are propelling Indiana to the forefront of medical advancements and transforming global health.

Indiana is one of the nation’s most productive life sciences hubs. From world-class exports and FDA approvals to record-breaking capital activity, the state offers investors a robust pipeline of opportunity across pharmaceuticals, biotech, medtech, diagnostics, and digital health.

Indiana Tax Credits

IEDC – Hoosier Business Investment Tax Credit

At a Glance

Eli Lilly, Roche, Cook Medical, Zimmer Biomet, and more.

#1 in U.S. life sciences exports

$27B annually

#1 in U.S pharmaceutical exports

$21B annually

926 patents granted

in 2024

100 FDA approvals

in 2024

$260M in venture capital funding

across 36 deals

$5.2B in M&A activity

in 2024 (including three $1B+ transactions)

$223M raised in public offerings

in 2024, up from $160.7M in 2023

Indiana’s Regional Strengths

Indiana is home to a growing number of regional life sciences and innovation hubs. From research and discovery to advanced manufacturing, our unique hubs are making groundbreaking advancements and transforming global healthcare.

Startups In Action

Showcasing fast-growing Indiana startups, exits, and recent funding rounds. Rotating feature cards with short blurbs, and links to company pages.

01 00

Events & Networking

Key touchpoints where investors connect with Indiana startups like National: BIO International, JPM Healthcare Conference, Rally Innovation Conference and Local: Odyssey, FrameWORX, pitch forums, peer networking via Venture Club.

Get Connected

Looking for startups that match your focus? BioCrossroads can connect you.